Cost Utility Analysis of Infliximab for the Treatment of Severe Rheumatoid Arthritis in Thailand
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.334
https://www.valueinhealthjournal.com/article/S1098-3015(14)02264-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2336
First Page :
A774
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02264-5&doi=10.1016/j.jval.2014.08.334